12 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive officer and chief scientific officer
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
decades of experience in cancer immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive … of experience in cancer immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive officer
DRS
ONCR
Oncorus, Inc.
28 Jan 21
Draft registration statement
12:00am
of experience in cancer immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive officer … immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive officer and chief scientific
424B4
ghdxp
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
akz exdsl01
11 Sep 20
IPO registration
4:49pm
DRS/A
zc1b 23cjs
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
tp52fix
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
mq7vuum9fvmbpfys
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
ra6oatnjftgfbd2a
31 Oct 19
Draft registration statement
12:00am
- Prev
- 1
- Next